Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Meloxicam
Emdoka bvba
QM01AC06
Meloxicam
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Horses
Anti Inflammatory NSAID
Authorized
2022-02-08
Issued: June 2021 AN: 01452/2019 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 15 mg/ml oral suspension for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Meloxicam 15.0 mg EXCIPIENTS: Sodium benzoate 1.5 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension Yellow suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses. 4.3 CONTRAINDICATIONS Do not use in pregnant or lactating mares. Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in horses less than 6 weeks of age. 4.4 SPECIAL WARNINGS None. Issued: June 2021 AN: 01452/2019 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of renal toxicity. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. This product can cause eye irritation. In case of contact with the eyes, immediately rinse thoroughly with water. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Isolated cases of adverse reactions typically associated with NSAIDs were observed in clinical trials (slight urticaria, diarrhoea). Symptoms were reversible. Loss of appetite, lethargy, abdominal pain and colitis have been reported in very rare cases. A Read the complete document